ID
42515
Descrizione
Study ID: 106464 Clinical Study ID: 106464 Study Title: A Study of the Efficacy Against Episodes of Clinical Malaria Due to P. Falciparum Infection of GSK Biologicals Candidate Vaccine RTS, S/AS01, Administered According to a 0,1,2-months Schedule in Children Aged 5 to 17 Months Living in Tanzania & Kenya Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00380393 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK malaria vaccine 257049 Vaccine, Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine Trade Name: N/A Study Indication: Malaria ODM derived from https://clinicaltrials.gov/ct2/show/study/NCT00380393. This Phase IIb randomized, double-blind, controlled study of the efficacy against episodes of clinical malaria due to Plasmodium falciparum infection of GlaxoSmithKline Biologicals’ candidate vaccine RTS, S/AS01E, administered IM according to a 0, 1, 2-month vaccination schedule in children aged 5 months to 17 months living in Tanzania and Kenya. This study includes the following 7 clinical study visits (3 different visit types) during a double-blind phase (Day -60 to Month 6 1/2) and a single-blind phase including an extension for a subset of patients (month 7 to month 14). Clinical visit 1: Baseline visit, screening, and randomisation (DAY -60 to 0) Clinical visit 2: Vaccination I (MONTH 0, DAY 0 | DOSE 1 | 0 - 60 DAYS AFTER VISIT 1) Clinical visit 3: Vaccination II (MONTH 1, DAY 30 | DOSE 2 | 21 - 35 DAYS AFTER VISIT 2) Clinical visit 4: Vaccination III (MONTH 2, DAY 60 | DOSE 3 | 21 - 35 DAYS AFTER VISIT 3) Clinical visit 5: Blood Sample, ACD (MONTH 3, DAY 90 | 21 - 42 DAYS AFTER VISIT 4) Clinical visit 6: Blood Sample, ACD (MONTH 6 1/2 | CROSS-SECTIONAL VISIT FOR ACD | FINAL STUDY VISIT FOR DOUBLE-BLIND PHASE) Clinical visit 7: Blood Sample, ACD (MONTH 14 | FINAL STUDY VISIT SINGLE-BLIND PHASE) Field-worker home visits: During the vaccination period, clinical visits are accompanied by daily field-worker visits for a one-week period subsequent to each vaccine administration at clinical visits 2, 3, and 4 (visit code 21-26 following clinical visit 2; visit code 27-32 following clinical visit 3; visit code 33-38 following clinical visit 4). After completion of the vaccination period, clinical visits are then accompanied by weekly field-worker home visits (visit code 39-40 following clinical visit 4/dose 3; visit code 41-55 following clinical visit 5; visit code 56-86 following clinical visit 6). These visits serve the additional purpose of Active Case Detection (ACD). Passive Case Detection (PCD) for clinical malaria disease is performed both during the course of the double-blind (day -60 to month 6 1/2) and the single-blind phase (month 7 to month 14). Laboratory reference range for each laboratory test should be documented in this form. If the reference ranges for any test differ by age range, age units or sex, a separate form for each variation should be completed. Note that informed consent has to be obtained prior to any study procedure.
collegamento
https://clinicaltrials.gov/ct2/show/study/NCT00380393
Keywords
versioni (1)
- 11/08/21 11/08/21 -
Titolare del copyright
GlaxoSmithKline
Caricato su
11 agosto 2021
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Efficacy of P. Falciparum Vaccine Against Malaria in Children NCT00380393
Laboratory Reference Ranges
- StudyEvent: ODM
Descrizione
Laboratory Reference Ranges
Alias
- UMLS CUI-1
- C0883335
Descrizione
Laboratory Reference Ranges
Alias
- UMLS CUI-1
- C0883335
Descrizione
Enter the reference range for each test. If the reference ranges for any test differ by age range, age units or sex, complete a separate version of this repeating item group for each variation (e.g., males 0-16, males 17-99, females 0- 16, females 17-99 years).
Tipo di dati
date
Alias
- UMLS CUI [1,1]
- C0883335
- UMLS CUI [1,2]
- C0011008
Descrizione
Age range low
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1514721
- UMLS CUI [1,3]
- C0205251
Descrizione
Age range high
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1514721
- UMLS CUI [1,3]
- C0205250
Descrizione
(tick one box) In the original paper-based version of this clinical study report, 'weeks' was pre-selected for this item.
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1519795
Descrizione
In the original paper-based version of this clinical study report, 'Male and Female reference range' was pre-selected for this item.
Tipo di dati
integer
Alias
- UMLS CUI [1]
- C0079399
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 5 U/L.
Tipo di dati
integer
Unità di misura
- U/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0201836
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 60 U/L.
Tipo di dati
integer
Unità di misura
- U/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0201836
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 10 µmol/L.
Tipo di dati
integer
Unità di misura
- µmol/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0201975
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 60 µmol/L.
Tipo di dati
integer
Unità di misura
- µmol/L
Alias
- UMLS CUI [1]
- C0008000
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0201975
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 8.0 g/dL.
Tipo di dati
float
Unità di misura
- g/dL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0518015
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 18 g/dL.
Tipo di dati
float
Unità di misura
- g/dL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0518015
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 4.0 x 10^3/µL
Tipo di dati
float
Unità di misura
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0023508
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 17 x 10^3/µL
Tipo di dati
float
Unità di misura
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0023508
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 100 x 10^3/µL
Tipo di dati
integer
Unità di misura
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1272773
- UMLS CUI [2,2]
- C0005821
Descrizione
In the original paper-based version of this clinical study report, this item was pre-filled with 800 x 10^3/µL
Tipo di dati
integer
Unità di misura
- 10^3/µL
Alias
- UMLS CUI [1]
- C0018941
- UMLS CUI [2,1]
- C1299400
- UMLS CUI [2,2]
- C0005821
Similar models
Laboratory Reference Ranges
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C2347796 (UMLS CUI [2,1])
C0457083 (UMLS CUI [2,2])
C0011008 (UMLS CUI [1,2])
C1514721 (UMLS CUI [1,2])
C0205251 (UMLS CUI [1,3])
C1514721 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,3])
C1272773 (UMLS CUI [2,1])
C0201836 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0201836 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0201975 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0201975 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0518015 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0518015 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0023508 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0023508 (UMLS CUI [2,2])
C1272773 (UMLS CUI [2,1])
C0005821 (UMLS CUI [2,2])
C1299400 (UMLS CUI [2,1])
C0005821 (UMLS CUI [2,2])